Gene · 3714
Papers2,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. | Front Cell Dev Biol | 2023 | 37860822 | PubTator, text mining | PubMed |
| Identification of disease modules using higher-order network structure. | Bioinform Adv | 2023 | 37860106 | PubTator, text mining | PubMed |
| Increased NOTCH1 expression is associated with low survival in moderate/ poor differentiated human oral squamous cell carcinoma patients. | J Cancer | 2023 | 37859809 | PubTator, text mining | PubMed |
γ-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells. | ACS Pharmacol Transl Sci | 2023 | 37854616 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Transcriptional Regulation of Airway Epithelial Cell Differentiation: Insights into the Notch Pathway and Beyond. | Int J Mol Sci | 2023 | 37834236 | PubTator, text mining | PubMed |
| Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells. | Int J Mol Sci | 2023 | 37834227 | PubTator, text mining | PubMed |
| Effects of an Adipose Mesenchymal Stem Cell-Derived Conditioned medium and TGF-β1 on Human Keratinocytes In Vitro. | Int J Mol Sci | 2023 | 37834173 | PubTator, text mining | PubMed |
| The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma. | Int J Mol Sci | 2023 | 37834003 | PubTator, text mining | PubMed |
| Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases. | Int J Mol Sci | 2023 | 37833928 | PubTator, text mining | PubMed |
| Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia. | Int J Mol Sci | 2023 | 37833915 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of human epidermis identifies Lunatic fringe as a novel regulator of the stem cell compartment. | Stem Cell Reports | 2023 | 37832539 | PubTator, text mining | PubMed |
| The odontoblastic differentiation of dental mesenchymal stem cells: molecular regulation mechanism and related genetic syndromes. | Front Cell Dev Biol | 2023 | 37818127 | PubTator, text mining | PubMed |
| Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis. | medRxiv | 2023 | 37808834 | PubTator, text mining | PubMed |
| NOTCH Pathway Genes in Ovarian Cancer: Clinical Significance and Associations with Immune Cell Infiltration. | Front Biosci (Landmark Ed) | 2023 | 37796700 | PubTator, text mining | PubMed |
| Aquatic Peptide: The Potential Anti-Cancer and Anti-Microbial Activity of GE18 Derived from Pathogenic Fungus Aphanomyces invadans. | Molecules | 2023 | 37764521 | PubTator, text mining | PubMed |
| Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies. | Cancers (Basel) | 2023 | 37760535 | PubTator, text mining | PubMed |
| The Relationship between Discrepancies in Career Anchors of Information Technology Personnel and Career Satisfaction. | Behav Sci (Basel) | 2023 | 37754063 | PubTator, text mining | PubMed |
| Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. | Front Oncol | 2023 | 37746261 | PubTator, text mining | PubMed |
| Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure. | Front Immunol | 2023 | 37744328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3714/papers?page=8